These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 5311148)

  • 1. Inhibition of thromboplastin-induced intravascular coagulation by heparin and Trasylol.
    Nordström S
    Acta Physiol Scand; 1970 Jul; 79(3):390-404. PubMed ID: 5311148
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of fibrinolytic inhibitors and heparin on induced intravascular coagulation.
    Nordström S
    Acta Physiol Scand Suppl; 1970; 337():1-35. PubMed ID: 5311663
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental investigations with proteinase inhibitors.
    Nordström S; Blombäck M; Olsson P; Zetterqvist E
    Acta Chir Scand Suppl; 1967; 378():33-40. PubMed ID: 5300105
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of epsilon aminocaproic acid (EACA) and Trasylol on thromboplastin-induced intravascular coagulation, studied in dogs with iodine-labelled fibrinogen.
    Nordstrm S; Zetterqvist E
    Acta Physiol Scand; 1969; 76(1):93-105. PubMed ID: 5307271
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of Trasylol on thromboplastin-induced arterial hypotension.
    Nordström S
    Acta Physiol Scand; 1970 Aug; 79(4):469-74. PubMed ID: 5312074
    [No Abstract]   [Full Text] [Related]  

  • 6. Experimental investigations on the antithromboplastic and antifibrinolytic activity of Trasylol.
    Nordström S; Blombäck B; Blombäck M; Olsson P; Zetterqvist E
    Ann N Y Acad Sci; 1968 Jun; 146(2):701-14. PubMed ID: 5305815
    [No Abstract]   [Full Text] [Related]  

  • 7. Tissue factor-induced coagulation can be inhibited by aprotinin (Trasylol).
    van den Besselaar AM; Dirven R; Bertina RM
    Thromb Haemost; 1993 Mar; 69(3):298-9. PubMed ID: 7682341
    [No Abstract]   [Full Text] [Related]  

  • 8. [Inhibition of the thromboplastic activity of amniotic fluid with Trasylol].
    Slunsky R
    Gynakol Rundsch; 1973; 13(2):147-52. PubMed ID: 4542664
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of reptilase-induced intravascular coagulation in dogs.
    Egberg N; Nordström S
    Acta Physiol Scand; 1970 Aug; 79(4):493-505. PubMed ID: 5312075
    [No Abstract]   [Full Text] [Related]  

  • 10. [Inhibition of the thromboplastic effect of placental extracts using trasylol].
    Slunsky R
    Z Geburtshilfe Perinatol; 1972 Jun; 176(3):201-6. PubMed ID: 4538438
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of protease inhibitor (trasylol) and heparin in cardiorespiratory resuscitation. I. Studies of the blood clotting system.
    Gaszyński W
    Anaesth Resusc Intensive Ther; 1975; 3(2):125-34. PubMed ID: 1080969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Trasylol on fibrin deposition and elimination in the lungs of rats with intravascular coagulation induced by thrombin or thromboplastin.
    Diffang C; Saldeen T
    Thromb Res; 1974 Sep; 5(3):263-76. PubMed ID: 4548231
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative effects of proteinase inhibitors, plasminogen antiactivators, heparin and acetylsalicylic acid on the experimental disseminated intravascular coagulation induced by thormbin.
    Moriau M; Rodhain J; Noel H; Beys-Col CD; Masure R
    Thromb Diath Haemorrh; 1974 Sep; 32(1):171-88. PubMed ID: 4281540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Trasylol as inhibitor of the thromboplastic effect of amniotic fluid and placental extracts].
    Slunsky R
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 98(3):338-45. PubMed ID: 4123098
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of Trasylol on blood coagulation and fibrinolysis after intravenous injection.
    Gormsen J
    Acta Chir Scand Suppl; 1967; 378():53-61. PubMed ID: 4966132
    [No Abstract]   [Full Text] [Related]  

  • 16. Heparin-enhanced inhibitors during reversible disseminated intravascular coagulation.
    Marbet GA; Griffith MJ; Roberts HR
    Scand J Clin Lab Invest Suppl; 1985; 178():95-8. PubMed ID: 3867125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of thromboplastic activity by Trasylol. In vitro investigations concerning the mechanism of inhibition.
    Amris CJ; Hilden M
    Scand J Haematol; 1967; 4(1):3-10. PubMed ID: 5298445
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of Trasylol on blood coagulation after intravenous injection.
    Gormsen J; Josephsen P
    Thromb Diath Haemorrh; 1967 Feb; 17(1-2):51-7. PubMed ID: 5300648
    [No Abstract]   [Full Text] [Related]  

  • 19. Paradoxic changes in platelets and fibrinogen in chronically induced intravascular coagulation.
    Cooper HA; Bowie EJ; Didisheim P; Owen CA
    Mayo Clin Proc; 1971 Aug; 46(8):521-3. PubMed ID: 5566135
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of a complex mixture of plasma proteins with heparin on the anticoagulation and fibrinolytic activity of the blood plasma in animals following intravenous administration of tissue thromboplastin].
    Pastorova VE
    Fiziol Zh SSSR Im I M Sechenova; 1988 Jun; 74(6):814-9. PubMed ID: 3181520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.